
  
    
      
        Introduction_NNP
        Passive_NNP leg_NN elevation_NN (_( PLE_NNP )_) is_VBZ a_DT common_JJ manoeuvre_NN
        performed_VBN to_TO prepare_VB the_DT sterile_JJ field_NN in_IN several_JJ surgical_JJ
        specialities_NNS (_( coronary_JJ surgery_NN ,_, vascular_NN and_CC orthopaedic_JJ
        surgery_NN )_) ,_, to_TO facilitate_VB surgical_JJ exposure_NN (_( gynaecologic_JJ and_CC
        urologic_JJ surgery_NN )_) or_CC to_TO treat_VB acute_JJ hypotension_NN ._. It_PRP is_VBZ well_RB
        known_VBN that_IN this_DT postural_NN change_NN induces_VBZ some_DT haemodynamic_JJ
        modifications_NNS represented_VBN by_IN the_DT shift_NN of_IN blood_NN from_IN the_DT
        legs_NNS into_IN the_DT central_JJ circulation_NN ,_, by_IN the_DT increase_NN in_IN the_DT
        venous_JJ return_NN and_CC by_IN the_DT improvement_NN in_IN systemic_JJ
        haemodynamics_NNS [_NN 1_CD ,_, 2_CD ,_, 3_CD ,_, 4_CD ]_NN ._. These_DT effects_NNS are_VBP more_RBR
        pronounced_JJ under_IN general_JJ anaesthesia_NN because_IN of_IN the_DT larger_JJR
        blood_NN sequestration_NN into_IN the_DT peripheral_JJ higher_JJR compliant_NN
        venous_JJ system_NN ,_, as_IN a_DT result_NN of_IN the_DT loss_NN in_IN the_DT muscular_JJ and_CC
        vascular_NN tone_NN induced_VBN by_IN the_DT anaesthetic_JJ drugs_NNS [_NN 1_CD ,_, 2_CD ]_NN ._. If_IN
        the_DT manoeuvre_NN can_MD be_VB utilized_JJ to_TO treat_VB acute_JJ hypotension_NN
        due_JJ to_TO hypovolaemia_NN ,_, it_PRP could_MD not_RB be_VB as_IN beneficial_JJ in_IN the_DT
        patient_NN with_IN a_DT compromised_VBN right_JJ ventricle_NN ,_, where_WRB acute_JJ
        volume_NN loading_NN may_MD lead_VB to_TO a_DT further_JJ deterioration_NN of_IN the_DT
        right_JJ ventricular_NN function_NN [_NN 5_CD ,_, 6_CD ,_, 7_CD ]_NN ._.
        Many_JJ experimental_JJ and_CC clinical_JJ studies_NNS have_VBP shown_VBN ,_,
        however_RB ,_, that_IN PLE_NNP has_VBZ no_DT or_CC little_RB haemodynamic_JJ benefit_NN in_IN
        normovolaemic_JJ patients_NNS with_IN a_DT stable_JJ cardiocirculatory_NN
        status_NN [_NN 2_CD ,_, 8_CD ,_, 9_CD ,_, 10_CD ,_, 11_CD ]_NN ._. Studying_NNP the_DT haemodynamic_JJ
        effects_NNS of_IN the_DT manoeuvre_NN in_IN anaesthetized_JJ coronary_JJ patients_NNS
        with_IN a_DT rapid-response_JJ thermistor_NN pulmonary_JJ artery_NN catheter_NN
        [_NN 12_CD ]_NN ,_, Reich_NNP 
        et_CC al_NN ._. concluded_VBD that_IN PLE_NNP results_NNS in_IN
        minor_JJ haemodynamic_JJ improvement_NN ,_, in_IN right_JJ ventricular_NN
        dilatation_NN and_CC in_IN right_JJ ventricular_NN ejection_NN fraction_NN
        (_( RVEF_NNP )_) decrease_VB [_NN 13_CD ]_NN ._. The_DT authors_NNS ,_, however_RB ,_, did_VBD not_RB
        differentiate_VB between_IN the_DT patients_NNS with_IN a_DT normal_JJ right_JJ
        ventricular_NN function_NN and_CC those_DT with_IN a_DT reduced_VBN right_JJ
        ventricular_NN function_NN ._. For_IN this_DT reason_NN ,_, we_PRP planned_VBD our_PRP$ study_NN
        in_IN order_NN to_TO evaluate_VB the_DT effects_NNS of_IN PLE_NNP on_IN the_DT right_JJ
        ventricle_NN with_IN the_DT same_JJ technique_NN ,_, comparing_VBG a_DT group_NN of_IN
        patients_NNS with_IN a_DT preinduction_NN RVEF_NNP >_NN 45_CD %_NN with_IN a_DT second_JJ
        group_NN of_IN patients_NNS with_IN preinduction_NN RVEF_NNP <_NN 40_CD %_NN ._.
      
      
        Methods_NNP
        Twenty_CD coronary_JJ patients_NNS scheduled_VBN for_IN elective_JJ
        myocardial_NN revascularization_NN were_VBD studied_VBN after_IN the_DT study_NN
        protocol_NN was_VBD approved_VBN by_IN the_DT local_JJ Ethics_NNP Committee_NNP and_CC the_DT
        written_VBN informed_VBN consent_NN was_VBD obtained_VBN from_IN each_DT patient_NN ._.
        The_DT admission_NN criteria_NNS to_TO the_DT study_NN were_VBD stable_JJ
        preoperative_JJ cardiocirculatory_NN conditions_NNS without_IN
        intravenous_JJ cardiovascular_JJ drugs_NNS ,_, no_DT evidence_NN of_IN valvular_NN
        disease_NN or_CC pulmonary_JJ hypertension_NN ,_, a_DT normal_JJ sinus_JJ rhythm_NN ,_,
        normovolaemia_NN and_CC no_DT diuretic_JJ therapy_NN ._.
        Preoperative_NNP cardiac_JJ medications_NNS (_( β-blockers_JJ ,_, calcium_NN
        channel_NN blockers_NNS ,_, nitroglycerin_NN )_) were_VBD continued_VBN until_IN the_DT
        day_NN of_IN surgery_NN ._.
        All_DT patients_NNS were_VBD premedicated_JJ with_IN intramuscular_NN
        morphine_NN (_( 0_CD ._. 1_LS mg_NN /_NN kg_NN )_) and_CC scopolamine_NN (_( 0_CD ._. 005_CD mg_NN /_NN kg_NN )_) 60_CD min_NN
        before_IN entering_VBG the_DT operating_NN room_NN ._. They_PRP were_VBD monitored_VBN by_IN
        electrocardiogram_NN (_( D_NNP II_NNP ,_, V_NNP 5_CD ,_, ST_NNP segment_NN analysis_NN )_) ,_, by_IN
        radial_NN artery_NN cannula_NN ,_, and_CC by_IN a_DT thermodilution_NN RVEF_NNP
        pulmonary_JJ artery_NN catheter_NN (_( model_NN 93_CD /_NN A-_NNP 432_CD H-_NNP 7_CD ._. 5_LS F_NN ;_: Baxter_NNP
        Edwards_NNP Healthcare_NNP Laboratories_NNPS ,_, Santa_NNP Ana_NNP ,_, CA_NNP ,_, USA_NNP )_)
        positioned_VBN before_IN induction_NN under_IN local_JJ anaesthesia_NN ._.
        General_JJ anaesthesia_NN was_VBD induced_VBN with_IN etomidate_NN (_( 0_CD ._. 15_CD
        mg_NN /_NN kg_NN )_) ,_, fentanyl_NN (_( 5_CD μg_NN /_NN kg_NN )_) and_CC vecuronium_NN (_( 0_CD ._. 1_LS mg_NN /_NN kg_NN )_) ,_, and_CC
        was_VBD maintained_VBN during_IN the_DT study_NN with_IN a_DT continuous_JJ infusion_NN
        of_IN midazolam_NN (_( 8_CD -_: 10_CD mg_NN /_NN hour_NN )_) ._. Mechanical_NNP ventilation_NN was_VBD
        provided_VBN with_IN an_DT oxygen_NN /_NN air_NN mixture_NN ,_, and_CC was_VBD adjusted_VBN to_TO
        maintain_VB the_DT arterial_NN carbon_NN dioxide_NN tension_NN between_IN 35_CD and_CC
        40_CD mmHg_NN and_CC to_TO maintain_VB the_DT arterial_NN oxygen_NN tension_NN higher_JJR
        than_IN 100_CD mmHg_NN ._. No_DT level_NN of_IN positive_JJ end-expiratory_JJ pressure_NN
        was_VBD applied_VBN ._. During_IN the_DT study_NN ,_, 2_CD -_: 3_CD ml_NN /_NN kg_NN fluids_NNS per_IN hour_NN
        were_VBD administered_VBN to_TO all_DT patients_NNS and_CC no_DT other_JJ drug_NN was_VBD
        used_VBN ._. After_IN endotracheal_NN intubation_NN ,_, a_DT two-dimensional_JJ
        transoesophageal_NN echocardiography_NN probe_NN was_VBD introduced_VBN into_IN
        the_DT oesophagus_JJ ._. The_DT probe_NN was_VBD connected_VBN to_TO an_DT
        ultrasonograph_NN device_NN (_( Color_NNP Doppler_NNP ,_, model_NN SSD-_NNP 830_CD ;_: Aloka_NNP
        Company_NNP ,_, Tokyo_NNP ,_, Japan_NNP )_) and_CC videorecording_VBG of_IN
        two-dimensional_JJ transoesophageal_NN echocardiography_NN images_NNS
        were_VBD made_VBN for_IN later_RB analysis_NN ._.
        A_DT complete_JJ haemodynamic_JJ profile_NN was_VBD performed_VBN before_IN
        induction_NN of_IN anaesthesia_NN (_( time_NN point_NN 1_LS )_) ,_, just_RB before_IN (_( time_NN
        point_NN 2_LS )_) and_CC 1_CD min_NN (_( time_NN point_NN 3_LS )_) after_IN the_DT patients_NNS had_VBD
        their_PRP$ legs_NNS simultaneously_RB raised_VBD at_IN an_DT angle_NN of_IN 60_CD °_NN ,_, and_CC 1_CD
        min_NN after_IN the_DT legs_NNS were_VBD lowered_VBN (_( time_NN point_NN 4_LS )_) ._. The_DT
        pressure_NN data_NN at_IN each_DT time_NN were_VBD recorded_VBN (_( the_DT right_JJ
        intraventricular_NN pressures_NNS advancing_VBG the_DT pulmonary_JJ artery_NN
        catheter_NN until_IN the_DT proximal_NN port_NN entered_VBD the_DT ventricular_NN
        chamber_NN )_) and_CC were_VBD then_RB followed_VBN by_IN injection_NN of_IN iced_JJ 5_CD %_NN
        glucose_NN solution_NN at_IN the_DT end_NN of_IN the_DT expiratory_NN time_NN ,_, until_IN
        three_CD values_NNS of_IN cardiac_JJ output_NN within_IN 10_CD %_NN of_IN each_DT other_JJ
        were_VBD obtained_VBN ._.
        Each_DT haemodynamic_JJ profile_NN consisted_VBD of_IN data_NNS recorded_VBN by_IN
        the_DT Hewlett_NNP Packard_NNP (_( Palo_NNP Alto_NNP ,_, CA_NNP ,_, USA_NNP )_) monitor_VB (_( model_NN
        7853_CD C_NNP )_) and_CC registered_VBN on_IN a_DT five-channel_JJ Hewlett_NNP Packard_NNP
        strip_NN chart_NN recorder_NN ,_, and_CC data_NNS recorded_VBN by_IN the_DT Explorer_NNP
        computer_NN (_( Baxter_NNP Edwards_NNP Healthcare_NNP Laboratories_NNPS )_) ._.
        The_DT first_JJ profile_NN measured_VBD the_DT heart_NN rate_NN ,_, the_DT systolic_JJ
        systemic_JJ pressure_NN ,_, the_DT diastolic_JJ systemic_JJ pressure_NN ,_, the_DT
        mean_JJ systemic_JJ pressure_NN ,_, the_DT mean_JJ pulmonary_JJ pressure_NN ,_, the_DT
        pulmonary_JJ capillary_JJ wedge_NN pressure_NN ,_, the_DT central_JJ venous_JJ
        pressure_NN ,_, the_DT right_JJ ventricular_NN diastolic_JJ pressure_NN ,_, the_DT
        right_JJ ventricular_NN end_NN diastolic_JJ pressure_NN measured_VBN at_IN the_DT
        interception_NN of_IN the_DT R_NN point_NN in_IN the_DT QRS_NNP complex_JJ with_IN the_DT
        intraventricular_NN pressure_NN trace_VB [_NN 14_CD ]_NN ,_, and_CC the_DT right_JJ
        ventricular_NN systolic_JJ pressure_NN ._. The_DT right_JJ ventricular_NN end_NN
        systolic_JJ pressure_NN was_VBD not_RB measured_VBN because_IN the_DT dicrotic_JJ
        notch_NN on_IN the_DT pulmonary_JJ artery_NN pressure_NN wave_NN was_VBD very_RB often_RB
        not_RB evident_JJ ._. All_DT pressures_NNS were_VBD measured_VBN on_IN the_DT strip_NN chart_NN
        at_IN the_DT end_NN of_IN the_DT expiratory_NN time_NN ._.
        The_DT other_JJ profile_NN measured_VBD the_DT right_JJ ventricular_NN end_NN
        diastolic_JJ volume_NN ,_, the_DT right_JJ ventricular_NN end_NN systolic_JJ
        volume_NN ,_, the_DT RVEF_NNP and_CC the_DT cardiac_JJ output_NN ._.
        The_DT derived_VBN parameters_NNS then_RB calculated_VBN were_VBD the_DT cardiac_JJ
        index_NN ,_, the_DT stroke_NN volume_NN index_NN ,_, the_DT right_JJ ventricular_NN end_NN
        diastolic_JJ volume_NN index_NN (_( RVEDVI_NNP )_) and_CC the_DT right_JJ ventricular_NN
        end_NN systolic_JJ volume_NN index_NN (_( RVESVI_NNP )_) ,_, the_DT right_JJ ventricular_NN
        end_NN diastolic_JJ volume_NN /_NN pressure_NN ratio_NN (_( RVED_NNP V_NNP /_NN P_NN )_) ,_, the_DT right_JJ
        ventricular_NN stroke_NN work_NN index_NN ,_, the_DT pressure_NN gradient_NN
        between_IN systolic_JJ systemic_JJ pressure_NN and_CC right_JJ ventricular_NN
        systolic_JJ pressure_NN (_( Δ_NN 
        p_NN 
        SSP_NNP /_NN RVSP_NNP )_) and_CC the_DT pressure_NN gradient_NN
        between_IN diastolic_JJ systemic_JJ pressure_NN and_CC the_DT mean_JJ right_JJ
        ventricular_NN diastolic_JJ pressure_NN (_( the_DT mean_JJ value_NN between_IN
        diastolic_JJ and_CC end_VB diastolic_JJ right_JJ ventricular_NN pressures_NNS )_) (_( Δ_NN
        
        p_NN 
        DSP_NNP /_NN mRVDP_NN )_) ._.
        The_DT patients_NNS were_VBD divided_VBN into_IN two_CD groups_NNS on_IN the_DT basis_NN
        of_IN the_DT RVEF_NNP measured_VBD at_IN time_NN point_NN 1_CD :_: the_DT patients_NNS of_IN group_NN
        A_DT had_VBD RVEF_NNP >_NN 45_CD %_NN ,_, and_CC the_DT patients_NNS of_IN group_NN B_NNP had_VBD RVEF_NNP
        <_NN 40_CD %_NN ._.
        Statistical_NNP analysis_NN was_VBD performed_VBN by_IN two-way_JJ analysis_NN
        of_IN variance_NN test_NN for_IN repeated_VBN measures_NNS with_IN a_DT Bonferroni_NNP
        correction_NN ,_, 
        P_NN <_NN 0_CD ._. 05_CD was_VBD considered_VBN
        significant_JJ ._. Results_NNS are_VBP expressed_VBN as_IN mean_NN ±_NN standard_JJ
        deviation_NN ._.
      
      
        Results_NNS
        Sixteen_NNP patients_NNS completed_VBD the_DT study_NN protocol_NN ._. Four_CD
        patients_NNS (_( two_CD from_IN each_DT group_NN )_) were_VBD excluded_VBN because_IN of_IN
        arrhythmias_NNS (_( one_CD patient_NN )_) ,_, because_IN of_IN intravenous_JJ
        administration_NN of_IN nitroglycerin_NN for_IN angina_NN (_( two_CD patients_NNS )_)
        and_CC because_IN of_IN moderate_JJ tricuspid_NN regurgitation_NN at_IN time_NN
        point_NN 3_CD (_( one_CD patient_NN )_) ._.
        The_DT general_JJ characteristics_NNS of_IN the_DT patients_NNS are_VBP reported_VBN
        in_IN Table_NNP 1_CD ._. There_EX are_VBP no_DT significant_JJ differences_NNS between_IN
        the_DT two_CD groups_NNS regarding_VBG age_NN ,_, left_VBD ventricular_NN ejection_NN
        fraction_NN ,_, preoperative_JJ therapy_NN and_CC the_DT number_NN of_IN right_NN and_CC
        left_VBD coronary_JJ stenoses_NNS ._.
        Comparing_VBG the_DT basal_NN values_NNS between_IN the_DT two_CD groups_NNS ,_, the_DT
        bedside_NN RVEF_NNP ,_, the_DT heart_NN rate_NN (_( 
        P_NN <_NN 0_CD ._. 01_CD )_) ,_, the_DT RVEDVI_NNP ,_, the_DT RVESVI_NNP
        (_( 
        P_NN <_NN 0_CD ._. 007_CD )_) and_CC the_DT RVED_NNP V_NNP /_NN P_NN (_( 
        P_NN <_NN 0_CD ._. 01_CD )_) were_VBD significantly_RB
        higher_JJR in_IN group_NN B_NNP than_IN in_IN group_NN A_DT (_( time_NN point_NN 1_CD ,_, Table_NNP 2_LS )_) ._.
        This_DT statistical_JJ difference_NN persisted_VBD at_IN time_NN point_NN 2_CD only_RB
        for_IN the_DT RVEF_NNP ,_, the_DT RVEDVI_NNP and_CC the_DT RVESVI_NNP ._.
        The_DT PLE_NNP induced_VBD similar_JJ changes_NNS in_IN heart_NN rate_NN ,_, which_WDT
        decreased_VBD significantly_RB ,_, in_IN both_DT groups_NNS and_CC induced_VBN similar_JJ
        changes_NNS in_IN the_DT majority_NN of_IN the_DT pressure_NN values_NNS (_( central_JJ
        venous_JJ pressure_NN ,_, right_JJ ventricular_NN diastolic_JJ pressure_NN ,_,
        right_JJ ventricular_NN end_NN diastolic_JJ pressure_NN ,_, pulmonary_JJ
        capillary_JJ wedge_NN pressure_NN )_) ,_, which_WDT increased_VBN significantly_RB at_IN
        time_NN point_NN 3_CD compared_VBN with_IN time_NN point_NN 2_CD (_( Table_NNP 2_LS )_) ._. On_IN the_DT
        contrary_NN ,_, the_DT systolic_JJ systemic_JJ pressure_NN ,_, the_DT diastolic_JJ
        systemic_JJ pressure_NN ,_, the_DT mean_JJ systemic_JJ pressure_NN and_CC the_DT mean_JJ
        pulmonary_JJ pressure_NN increased_VBD significantly_RB only_RB in_IN group_NN A_DT
        at_IN the_DT same_JJ time_NN point_NN ._.
        The_DT main_JJ differences_NNS between_IN the_DT two_CD groups_NNS after_IN the_DT
        legs_NNS were_VBD raised_VBN are_VBP represented_VBN ,_, however_RB ,_, by_IN the_DT changes_NNS
        in_IN the_DT data_NNS regarding_VBG volumes_NNS (_( Table_NNP 2_LS )_) ._. In_IN group_NN A_DT ,_, at_IN
        time_NN point_NN 3_CD versus_CC time_NN point_NN 2_CD ,_, in_IN the_DT face_NN of_IN a_DT slight_JJ
        and_CC not_RB significant_JJ increase_NN in_IN cardiac_JJ index_NN ,_, we_PRP observed_VBD
        a_DT significant_JJ increase_NN in_IN the_DT stroke_NN volume_NN index_NN (_( 
        P_NN <_NN 0_CD ._. 003_CD )_) ,_, the_DT RVEDVI_NNP (_( 
        P_NN <_NN 0_CD ._. 008_CD )_) and_CC the_DT RVESVI_NNP (_( 
        P_NN <_NN 0_CD ._. 006_CD )_) ._. However_RB ,_, the_DT RVEF_NNP was_VBD
        unchanged_JJ and_CC the_DT RVED_NNP V_NNP /_NN P_NN slightly_RB decreased_VBD ._.
        Moreover_RB ,_, the_DT right_JJ ventricular_NN stroke_NN work_NN index_NN (_( 
        P_NN <_NN 0_CD ._. 01_CD )_) ,_, the_DT Δ_NN 
        p_NN 
        SSP_NNP /_NN RVSP_NNP (_( 
        P_NN <_NN 0_CD ._. 01_CD )_) and_CC the_DT Δ_NN 
        p_NN 
        DSP_NNP /_NN mRVDP_NN (_( 
        P_NN <_NN 0_CD ._. 009_CD )_) significantly_RB increased_VBN
        at_IN the_DT same_JJ time_NN ._. At_IN time_NN point_NN 3_CD ,_, the_DT Δ_NN 
        p_NN 
        DSP_NNP /_NN mRVDP_NN change_NN was_VBD statistically_RB
        significant_JJ between_IN the_DT two_CD groups_NNS ._.
        An_DT opposite_JJ haemodynamic_JJ behaviour_NN was_VBD observed_VBN at_IN time_NN
        point_NN 3_CD in_IN group_NN B_NNP ._. In_IN fact_NN ,_, while_IN the_DT cardiac_JJ index_NN
        remained_VBD stable_JJ and_CC the_DT stroke_NN volume_NN index_NN increased_VBD
        slightly_RB ,_, the_DT RVEDVI_NNP (_( 
        P_NN <_NN 0_CD ._. 04_CD )_) and_CC the_DT RVED_NNP V_NNP /_NN P_NN (_( 
        P_NN <_NN 0_CD ._. 02_CD )_) significantly_RB decreased_VBD ._.
        The_DT RVEF_NNP increased_VBD and_CC the_DT RVESVI_NNP decreased_VBD ,_, but_CC not_RB
        significantly_RB ._. No_DT significant_JJ change_NN was_VBD recorded_VBN in_IN the_DT
        right_JJ ventricular_NN stroke_NN work_NN index_NN ,_, the_DT Δ_NN 
        p_NN 
        SSP_NNP /_NN RVSP_NNP and_CC the_DT Δ_NN 
        p_NN 
        DSP_NNP /_NN mRVDP_NN ._.
        The_DT graphic_JJ representation_NN of_IN the_DT relationship_NN between_IN
        right_JJ ventricular_NN end_NN diastolic_JJ volume_NN and_CC right_JJ
        ventricular_NN end_NN diastolic_JJ pressure_NN shows_VBZ the_DT upward_RB and_CC
        left_VBD side_NN movement_NN of_IN this_DT ratio_NN in_IN the_DT patients_NNS of_IN group_NN
        A_DT ,_, and_CC shows_VBZ the_DT upward_RB and_CC right_JJ side_NN movement_NN in_IN the_DT
        patients_NNS of_IN group_NN B_NNP (_( Fig_NNP ._. 1_LS )_) ._. After_IN the_DT legs_NNS had_VBD been_VBN
        lowered_VBN ,_, the_DT haemodynamic_JJ parameters_NNS (_( time_NN point_NN 4_LS )_) nearly_RB
        returned_VBD to_TO the_DT same_JJ values_NNS recorded_VBN at_IN time_NN point_NN 2_CD ._.
        The_DT transoesophageal_NN echocardiographic_JJ images_NNS did_VBD not_RB
        show_VB any_DT episode_NN of_IN tricuspid_NN regurgitation_NN ,_, and_CC no_DT
        apparent_JJ displacement_NN of_IN the_DT interventricular_NN septum_NN in_IN the_DT
        patients_NNS who_WP completed_VBD the_DT study_NN protocol_NN ._.
        No_DT ST_NNP segment_NN change_NN was_VBD observed_VBN in_IN any_DT patient_NN at_IN the_DT
        four_CD times_NNS of_IN the_DT study_NN ._.
      
      
        Discussion_NNP
        Many_JJ investigators_NNS have_VBP examined_VBN the_DT haemodynamic_JJ
        effects_NNS of_IN passive_JJ leg_NN raising_VBG with_IN different_JJ monitoring_NN
        techniques_NNS ._. Wong_NNP 
        et_CC al_NN ._. ,_, using_VBG thoracic_JJ bioimpedence_NN ,_,
        showed_VBD a_DT small_JJ but_CC significant_JJ increase_NN in_IN cardiac_JJ index_NN
        after_IN PLE_NNP in_IN awake_JJ patients_NNS (_( American_NNP Society_NNP of_IN
        Anaesthesiologists_NNP score_NN index_NN II_NNP and_CC III_NNP )_) undergoing_VBG
        elective_JJ operations_NNS [_NN 3_CD ]_NN ._. Rutlen_NNP 
        et_CC al_NN ._. ,_, using_VBG nuclear_JJ scintigraphy_NN ,_,
        reported_VBD that_IN 150_CD ml_NN or_CC less_JJR of_IN blood_NN transferred_VBN to_TO the_DT
        intravascular_NN space_NN after_IN leg_NN elevation_NN [_NN 15_CD ]_NN ._. Kyriakides_NNP 
        et_CC al_NN ._. ,_, employing_VBG a_DT Doppler_NNP
        echocardiographic_JJ technique_NN ,_, showed_VBD that_IN the_DT postural_NN
        change_NN increases_NNS preload_NN and_CC cardiac_JJ performance_NN in_IN
        normovolaemic_JJ coronary_JJ patients_NNS [_NN 10_CD ]_NN ._. However_RB ,_, studying_VBG
        the_DT effects_NNS of_IN PLE_NNP on_IN anaesthetized_JJ coronary_JJ patients_NNS by_IN a_DT
        rapid-response_JJ pulmonary_JJ artery_NN catheter_NN for_IN measurement_NN of_IN
        RVEF_NNP and_CC volumes_NNS [_NN 12_CD ]_NN ,_, Reich_NNP 
        et_CC al_NN ._. found_VBD no_DT improvement_NN in_IN
        cardiac_JJ performance_NN [_NN 13_CD ]_NN ._.
        Our_PRP$ results_NNS are_VBP in_IN agreement_NN with_IN the_DT conclusions_NNS drawn_VBN
        by_IN the_DT previous_JJ authors_NNS ;_: in_IN fact_NN ,_, a_DT slight_JJ increase_NN or_CC no_DT
        increase_NN in_IN cardiac_JJ index_NN was_VBD seen_VBN in_IN all_PDT the_DT patients_NNS
        studied_VBN ._. The_DT haemodynamic_JJ response_NN of_IN the_DT right_JJ ventricle_NN
        to_TO the_DT postural_NN change_NN was_VBD quite_RB different_JJ in_IN the_DT two_CD
        groups_NNS of_IN patients_NNS ,_, however_RB ,_, according_VBG to_TO the_DT basal_NN right_JJ
        ventricular_NN function_NN recorded_VBN before_IN the_DT induction_NN of_IN
        anaesthesia_NN ._.
        In_IN the_DT patients_NNS with_IN a_DT higher_JJR basal_NN RVEF_NNP and_CC lower_JJR right_JJ
        ventricular_NN volumes_NNS ,_, the_DT haemodynamic_JJ behaviour_NN was_VBD similar_JJ
        to_TO that_DT described_VBN by_IN Reich_NNP 
        et_CC al_NN ._. [_NN 13_CD ]_NN ._. The_DT right_JJ ventricular_NN
        end_NN diastolic_JJ volume_NN increased_VBN more_JJR than_IN the_DT right_JJ
        ventricular_NN end_NN systolic_JJ volume_NN and_CC ,_, as_IN the_DT RVEF_NNP did_VBD not_RB
        change_VB ,_, the_DT stroke_NN volume_NN increased_VBD ._. The_DT cardiac_JJ index_NN
        increased_VBD only_RB slightly_RB because_IN of_IN the_DT reduction_NN in_IN the_DT
        heart_NN rate_NN ._.
        Moreover_RB ,_, the_DT rise_NN in_IN right_JJ ventricular_NN end_NN diastolic_JJ
        pressure_NN did_VBD not_RB significantly_RB affect_VB right_JJ ventricular_NN
        compliance_NN [_NN 16_CD ]_NN ,_, to_TO which_WDT myocardial_NN wall_NN stress_NN and_CC
        oxygen_NN consumption_NN are_VBP inversely_RB related_VBN [_NN 5_CD ,_, 17_CD ]_NN ,_, because_IN
        the_DT pressure_NN increase_NN was_VBD proportional_JJ to_TO that_DT of_IN the_DT end_NN
        diastolic_JJ volume_NN ._. The_DT significant_JJ increase_NN in_IN the_DT pressure_NN
        gradient_NN between_IN radial_NN artery_NN pressures_NNS (_( generally_RB equal_JJ
        to_TO aortic_JJ pressures_NNS )_) and_CC the_DT right_JJ intraventricular_NN
        pressures_NNS ,_, whose_WP$ gradient_NN is_VBZ considered_VBN a_DT good_JJ index_NN of_IN
        coronary_JJ perfusion_NN pressure_NN [_NN 6_CD ]_NN ,_, may_MD have_VB improved_VBN the_DT
        right_NN coronary_JJ driving_NN pressure_NN ._. All_DT these_DT findings_NNS lead_VBP us_PRP
        to_TO conclude_VB that_DT leg_NN elevation_NN induced_VBD a_DT favourable_JJ
        condition_NN in_IN the_DT right_JJ ventricle_NN of_IN these_DT patients_NNS ._.
        On_IN the_DT contrary_NN ,_, with_IN the_DT right_JJ ventricles_NNS dilated_JJ and_CC a_DT
        lower_JJR basal_NN ejection_NN fraction_NN ,_, the_DT manoeuvre_NN of_IN raising_VBG the_DT
        legs_NNS was_VBD followed_VBN by_IN a_DT decrease_NN in_IN end_NN diastolic_JJ volume_NN
        index_NN and_CC end_VB systolic_JJ volume_NN index_NN ,_, and_CC by_IN a_DT small_JJ
        increase_NN in_IN ejection_NN fraction_NN and_CC stroke_NN volume_NN ,_, while_IN the_DT
        cardiac_JJ index_NN was_VBD unchanged_JJ because_IN of_IN the_DT reduction_NN in_IN the_DT
        heart_NN rate_NN ._. The_DT reduction_NN of_IN the_DT ventricular_NN size_NN seemed_VBD to_TO
        be_VB advantageous_JJ because_IN ,_, according_VBG to_TO the_DT Frank-_NNP Starling_NNP
        relationship_NN ,_, the_DT right_JJ ventricle_NN accomplished_VBN the_DT same_JJ
        work_NN with_IN a_DT smaller_JJR end_NN diastolic_JJ volume_NN and_CC a_DT shorter_JJR
        fibre_NN length_NN [_NN 18_CD ,_, 19_CD ]_NN ._. The_DT concomitant_NN increase_NN in_IN the_DT
        right_JJ ventricular_NN end_NN diastolic_JJ pressure_NN ,_, however_RB ,_, led_VBN to_TO a_DT
        marked_VBN reduction_NN in_IN the_DT right_JJ ventricular_NN compliance_NN ,_, with_IN
        adverse_JJ effects_NNS on_IN ventricular_NN wall_NN stress_NN and_CC oxygen_NN
        consumption_NN [_NN 5_CD ,_, 16_CD ,_, 17_CD ]_NN ._.
        Another_DT difference_NN in_IN group_NN B_NNP was_VBD the_DT lack_NN of_IN increase_NN
        in_IN the_DT pressure_NN gradient_NN between_IN the_DT radial_NN artery_NN and_CC the_DT
        right_JJ ventricular_NN cavity_NN after_IN the_DT legs_NNS were_VBD raised_VBN ._. This_DT
        haemodynamic_JJ event_NN ,_, combined_VBN with_IN stability_NN in_IN the_DT cardiac_JJ
        index_NN ,_, did_VBD not_RB offer_VB a_DT significant_JJ gain_NN to_TO the_DT right_JJ
        ventricular_NN oxygen_NN supply_NN ._.
        We_PRP have_VBP to_TO underline_VB ,_, however_RB ,_, that_IN the_DT conclusions_NNS
        drawn_VBN on_IN the_DT right_JJ ventricular_NN oxygen_NN supply_NN /_NN demand_NN ratio_NN
        in_IN the_DT two_CD loading_NN conditions_NNS are_VBP mainly_RB speculative_JJ ._. This_DT
        is_VBZ because_IN they_PRP are_VBP deduced_JJ from_IN indirect_JJ indicators_NNS
        (_( intraventricular_NN volumes_NNS and_CC pressures_NNS )_) of_IN the_DT myocardial_NN
        metabolic_JJ balance_NN ,_, and_CC they_PRP do_VBP not_RB allow_VB a_DT direct_JJ
        measurement_NN of_IN the_DT oxygen_NN supplied_VBN or_CC extracted_VBN by_IN the_DT
        heart_NN [_NN 5_CD ,_, 6_CD ,_, 16_CD ,_, 17_CD ]_NN ._. Nevertheless_RB ,_, we_PRP believe_VBP that_IN the_DT
        variations_NNS of_IN the_DT parameters_NNS measured_VBN in_IN our_PRP$ patients_NNS can_MD
        help_VB the_DT anaesthesiologist_NN and_CC the_DT intensivist_NN to_TO
        understand_VB or_CC to_TO predict_VB the_DT physiopathological_JJ changes_NNS
        that_WDT occur_VBP in_IN the_DT right_JJ ventricle_NN after_IN the_DT legs_NNS are_VBP
        raised_VBN ,_, also_RB because_IN the_DT haemodynamic_JJ data_NN used_VBN can_MD be_VB
        easily_RB available_JJ in_IN the_DT clinical_JJ anaesthesiological_JJ and_CC
        intensive_JJ care_NN setting_NN ._.
        Our_PRP$ protocol_NN included_VBD the_DT ejection_NN fraction_NN as_IN a_DT tool_NN to_TO
        divide_VB the_DT patients_NNS on_IN the_DT basis_NN of_IN the_DT right_JJ ventricular_NN
        function_NN ._. This_DT parameter_NN shows_VBZ important_JJ limitations_NNS as_IN an_DT
        index_NN of_IN ventricular_NN function_NN ._. In_IN fact_NN ,_, ejection_NN fraction_NN
        is_VBZ preload_NN and_CC afterload_NN dependent_JJ ,_, and_CC it_PRP correlates_NNS
        poorly_RB with_IN myocardial_NN contractility_NN ._. It_PRP is_VBZ therefore_RB not_RB a_DT
        specific_JJ parameter_NN ,_, since_IN its_PRP$ variation_NN is_VBZ due_JJ to_TO the_DT
        changes_NNS of_IN one_CD or_CC more_JJR of_IN the_DT related_VBN factors_NNS (_( preload_NN ,_,
        afterload_NN or_CC contractility_NN )_) [_NN 20_CD ,_, 21_CD ]_NN ._. Ejection_NNP fraction_NN ,_,
        more_JJR than_IN a_DT measurement_NN of_IN ventricular_NN performance_NN ,_, can_MD
        consequently_RB be_VB considered_VBN as_IN a_DT measurement_NN of_IN the_DT
        integrated_VBN cardiovascular_JJ system_NN in_IN dealing_VBG with_IN a_DT
        pathological_JJ process_NN [_NN 20_CD ]_NN ._. However_RB ,_, in_IN spite_NN of_IN these_DT
        limitations_NNS ,_, we_PRP used_VBD the_DT ejection_NN fraction_NN to_TO define_VB the_DT
        basal_NN right_JJ ventricular_NN function_NN of_IN our_PRP$ patients_NNS ,_, because_IN
        this_DT parameter_NN is_VBZ measured_VBN by_IN the_DT pulmonary_JJ catheter_NN we_PRP
        used_VBD and_CC because_IN it_PRP is_VBZ the_DT one_CD we_PRP use_VBP in_IN our_PRP$ clinical_JJ
        department_NN for_IN this_DT purpose_NN ._.
        The_DT attempt_NN to_TO correlate_VBP the_DT haemodynamic_JJ response_NN of_IN
        the_DT right_JJ ventricle_NN to_TO leg_NN elevation_NN with_IN the_DT degree_NN and_CC
        the_DT number_NN of_IN right_NN coronary_JJ artery_NN stenoses_NNS was_VBD
        unsuccessful_JJ because_IN the_DT coronary_JJ obstructions_NNS were_VBD equally_RB
        distributed_VBN in_IN the_DT two_CD groups_NNS ._. It_PRP would_MD therefore_RB not_RB have_VB
        been_VBN possible_JJ to_TO predict_VB from_IN the_DT coronarographic_JJ data_NN the_DT
        haemodynamic_JJ changes_NNS of_IN the_DT right_JJ ventricle_NN that_WDT followed_VBD
        the_DT passive_JJ leg_NN raising_VBG manoeuvre_NN ._.
        When_WRB analysing_VBG the_DT haemodynamic_JJ data_NN ,_, a_DT difficulty_NN can_MD
        arise_VB in_IN interpreting_VBG the_DT pulmonary_JJ capillary_JJ wedge_NN
        pressure_NN increase_NN ;_: whether_IN this_DT change_NN is_VBZ due_JJ to_TO an_DT
        increase_NN in_IN left_JJ ventricular_NN preload_NN that_WDT follows_VBZ the_DT
        increase_NN in_IN venous_JJ return_NN ,_, or_CC to_TO a_DT decrease_NN in_IN left_JJ
        ventricular_NN compliance_NN as_IN a_DT result_NN of_IN the_DT leftward_NN shift_NN of_IN
        the_DT interventricular_NN septum_NN for_IN right_JJ ventricular_NN
        dilatation_NN [_NN 16_CD ,_, 22_CD ]_NN ._. As_IN the_DT wedge_NN pressure_NN also_RB increased_VBD
        in_IN the_DT patients_NNS of_IN group_NN B_NNP ,_, whose_WP$ right_JJ ventricular_NN volume_NN
        decreased_VBD after_IN PLE_NNP ,_, and_CC the_DT transoesophageal_NN
        echocardiographic_JJ images_NNS did_VBD not_RB show_VB any_DT apparent_JJ shift_NN of_IN
        the_DT interventricular_NN septum_NN in_IN all_DT patients_NNS ,_, we_PRP conclude_VBP
        that_IN the_DT increase_NN in_IN preload_NN may_MD have_VB been_VBN the_DT probable_JJ
        explanation_NN for_IN this_DT haemodynamic_JJ change_NN ._.
        The_DT medication_NN drugs_NNS given_VBN to_TO the_DT patients_NNS before_IN
        surgery_NN (_( nitroglycerin_NN ,_, β-blockers_JJ ,_, calcium_NN antagonists_NNS )_)
        and_CC the_DT anaesthetic_JJ treatment_NN (_( drugs_NNS ,_, mechanical_JJ
        ventilation_NN )_) may_MD have_VB interfered_VBD significantly_RB with_IN the_DT
        cardiovascular_JJ function_NN and_CC the_DT haemodynamic_JJ data_NN recorded_VBN
        at_IN the_DT four_CD time_NN points_NNS of_IN the_DT study_NN [_NN 23_CD ,_, 24_CD ,_, 25_CD ,_, 26_CD ,_, 27_CD ]_NN ._.
        However_RB ,_, as_IN the_DT drugs_NNS administered_VBN before_IN surgery_NN were_VBD
        distributed_VBN equally_RB in_IN the_DT two_CD groups_NNS and_CC the_DT
        anaesthesiological_JJ treatment_NN was_VBD the_DT same_JJ for_IN all_DT patients_NNS ,_,
        we_PRP believe_VBP that_IN this_DT interference_NN can_MD be_VB considered_VBN
        negligible_JJ in_IN the_DT evaluation_NN of_IN the_DT haemodynamic_JJ
        differences_NNS observed_VBD in_IN the_DT patients_NNS studied_VBN ._.
        Concerning_VBG the_DT data_NNS recorded_VBN by_IN the_DT thermodilution_NN right_JJ
        ventricular_NN ejection_NN fraction_NN pulmonary_JJ artery_NN catheter_NN ,_,
        the_DT absence_NN of_IN episodes_NNS of_IN tricuspid_NN regurgitation_NN (_( a_DT
        condition_NN that_WDT can_MD lead_VB to_TO underestimating_VBG cardiac_JJ output_NN
        and_CC RVEF_NNP [_NN 6_CD ,_, 12_CD ,_, 28_CD ]_NN )_) made_VBD those_DT parameters_NNS reliable_JJ and_CC
        comparable_JJ with_IN the_DT parameters_NNS recorded_VBN before_IN the_DT
        elevation_NN of_IN the_DT legs_NNS ._.
        Another_DT limitation_NN of_IN the_DT present_JJ study_NN is_VBZ represented_VBN
        by_IN the_DT number_NN of_IN patients_NNS studied_VBN ,_, which_WDT should_MD be_VB larger_JJR
        to_TO have_VB more_RBR statistical_JJ weight_NN and_CC to_TO provide_VB additional_JJ
        support_NN for_IN definitive_JJ conclusions_NNS ._. However_RB ,_, in_IN spite_NN of_IN
        the_DT limitations_NNS described_VBD and_CC the_DT expectation_NN of_IN further_JJ
        investigations_NNS confirming_VBG our_PRP$ results_NNS ,_, we_PRP conclude_VBP that_IN the_DT
        manoeuvre_NN of_IN leg_NN elevation_NN ,_, necessary_JJ to_TO prepare_VB the_DT
        sterile_JJ field_NN in_IN several_JJ surgical_JJ specialities_NNS (_( coronary_JJ ,_,
        vascular_NN and_CC orthopaedic_JJ surgery_NN )_) or_CC to_TO position_VB the_DT
        patient_NN for_IN some_DT gynaecologic_JJ and_CC urologic_JJ procedures_NNS ,_, must_MD
        be_VB performed_VBN slowly_RB and_CC progressively_RB in_IN normovolaemic_JJ
        coronary_JJ patients_NNS with_IN a_DT reduced_VBN right_JJ ventricular_NN function_NN
        because_IN it_PRP could_MD decompensate_NN the_DT already_RB poor_JJ balance_NN of_IN
        oxygen_NN supply_NN /_NN demand_NN in_IN the_DT right_JJ ventricle_NN ._.
        We_PRP finally_RB suggest_VBP that_IN ,_, as_IN the_DT main_JJ physiopathological_JJ
        changes_NNS of_IN PLE_NNP are_VBP caused_VBN by_IN the_DT increase_NN in_IN venous_JJ return_NN
        to_TO the_DT right_JJ ventricle_NN and_CC they_PRP are_VBP common_JJ to_TO those_DT induced_VBN
        by_IN the_DT administration_NN of_IN fluids_NNS ,_, the_DT manoeuvre_NN of_IN fluid_JJ
        loading_NN should_MD be_VB performed_VBN cautiously_RB and_CC progressively_RB in_IN
        such_JJ coronary_JJ patients_NNS ._. Even_RB if_IN this_DT statement_NN seems_VBZ
        obvious_JJ and_CC other_JJ authors_NNS have_VBP drawn_VBN the_DT same_JJ conclusions_NNS [_NN
        5_CD ]_NN ,_, further_JJ work_NN needs_VBZ to_TO be_VB carried_VBN out_IN in_IN this_DT area_NN to_TO
        confirm_VB such_PDT a_DT hypothesis_NNS ._.
      
      
        Competing_VBG interests_NNS
        None_NN declared_VBD ._.
      
      
        Key_JJ messages_NNS
        •_NN PLE_NNP brings_VBZ a_DT slight_JJ benefit_NN in_IN coronary_JJ patients_NNS with_IN
        a_DT normal_JJ RVEF_NNP ,_, but_CC causes_NNS no_DT benefit_NN or_CC adverse_JJ effects_NNS
        (_( decreased_VBD right_JJ ventricular_NN compliance_NN ,_, unchanged_JJ radial_NN
        artery_NN pressure-right_JJ intraventricular_NN pressure_NN gradient_NN
        and_CC cardiac_JJ index_NN )_) in_IN right_JJ ventricles_NNS with_IN a_DT reduced_VBN
        ejection_NN fraction_NN
        •_NN PLE_NNP must_MD be_VB performed_VBN slowly_RB in_IN anaesthetized_JJ coronary_JJ
        patients_NNS with_IN a_DT reduced_VBN right_JJ ventricular_NN basal_NN
        function_NN
        •_NN The_DT same_JJ caution_NN should_MD also_RB be_VB taken_VBN in_IN administering_VBG
        fluids_NNS to_TO such_JJ coronary_JJ patients_NNS
      
      
        Abbreviations_NNP
        Δ_NN 
        p_NN 
        SSP_NNP /_NN RVSP_NNP =_SYM pressure_NN gradient_NN between_IN
        systolic_JJ systemic_JJ pressure_NN and_CC right_JJ ventricular_NN systolic_JJ
        pressure_NN ;_: Δ_NN 
        p_NN 
        DSP_NNP /_NN mRVDP_NN =_SYM pressure_NN gradient_NN between_IN
        diastolic_JJ systemic_JJ pressure_NN and_CC the_DT mean_JJ right_JJ ventricular_NN
        diastolic_JJ pressure_NN (_( the_DT mean_JJ value_NN between_IN diastolic_JJ and_CC
        end_VB diastolic_JJ right_JJ ventricular_NN pressures_NNS )_) ;_: PLE_NNP =_SYM passive_JJ
        leg_NN elevation_NN ;_: RVEDVI_NNP =_SYM right_JJ ventricular_NN end_NN diastolic_JJ
        volume_NN index_NN ;_: RVED_NNP V_NNP /_NN P_NN =_SYM right_JJ ventricular_NN end_NN diastolic_JJ
        volume_NN /_NN pressure_NN ratio_NN ;_: RVEF_NNP =_SYM right_JJ ventricular_NN ejection_NN
        fraction_NN ;_: RVESVI_NNP =_SYM right_JJ ventricular_NN end_NN systolic_JJ volume_NN
        index_NN ._.
      
    
  
